Allergy to aminophylline: lack of predictability by skin testing.
Problems with determining hypersensitivity to aminophylline, ethylenediamine, and theophylline with intradermal skin tests and patch tests are reported in three patients. Three patients were tested with intradermal injections of 0.9% sodium chloride, 1% aminophylline, 1% ethylenediamine, and 0.5% theophylline following apparent allergic reactions to aminophylline. Patch testing using hydrophilic ointment base, 1% aminophylline, 1% ethylenediamine, and 0.5% theophylline was also done. All three patients had no reaction to intradermal sodium chloride or theophylline; all patch tests were negative. The first patient reacted to ethylenediamine strongly and to aminophylline more weakly; punch biopsy of the ethylenediamine reaction site showed a direct toxic effect with no allergic component. Punch biopsy of the aminophylline site showed a typical hypersensitivity reaction. Two concentrations (0.5% and 1.0%) of ethylenediamine injection were used to test the second patient, and he reacted to both concentrations but not to any other injections. His positive reactions contained blisters rather than the typical wheal-and-flare reaction of hypersensitivity. The third patient had similar responses including reactions to 0.5% and 0.1% ethylenediamine (he was not tested with 1% ethylenediamine). Skin testing may be of value in predicting aminophylline or ethylenediamine allergy, but the nonspecific toxic effect of ethylenediamine makes interpretation difficult.
D000368:Aged; D000628:Aminophylline / Q000009:adverse effects*; D003951:Diagnostic Errors; D004342:Drug Hypersensitivity / Q000175:diagnosis*; D005029:Ethylenediamines / Q000009:adverse effects; D006801:Humans; D007428:Intradermal Tests; D008297:Male; D008875:Middle Aged; D010328:Patch Tests; D012882:Skin Tests; D013806:Theophylline / Q000009:adverse effects
D005029:Ethylenediamines; D000628:Aminophylline; D013806:Theophylline